Advances in sampling and screening for chlamydia

References

• 1  Schachter J, Stephens RS. Biology of Chlamydia trachomatis. In: Sexually Transmitted Disease (4th Edition). Holmes KK, Sparling PF, Stamm WE et al. (Eds). McGraw-Hill, NY, USA, 555–574 (2008).
  Google Scholar
• 2  WHO. Global Incidence and Prevalence of Selected Curable Sexually Transmitted Infections. WHO, Switzerland (2012).
  Google Scholar
• 3  CDC. CDC Grand Rounds: chlamydia prevention: challenges and strategies for reducing disease burden and sequelae. MMWR Morb. Mortal. Wkly Rep.60(12),370–373 (2011).
  MedlineGoogle Scholar
• 4  Vickers DM, Osgood ND. Current crisis or artifact of surveillance: insights into rebound chlamydia rates from dynamic modelling. BMC Infect. Dis.10,70 (2010).
  MedlineGoogle Scholar
• 5  O’Rouke K, Fairley C, Samaranayake A, Collingnon P, Hocking J. Trends in chlamydia positivity over time among women in Melbourne Australia, 2003–2007. Sex. Transm. Dis.36(12),763–767 (2009).
  MedlineGoogle Scholar
• 6  Vodstrcil LA, Fairley CK, Fehler G et al. Trends in chlamydia and gonorrhea positivity among heterosexual men and men who have sex with men attending a large urban sexual health service in Australia, 2002–2009. BMC Infect. Dis.11,158 (2011).
  MedlineGoogle Scholar
• 7  Goetz H, Lindbaèck J, Ripa T, Malin Arneborn, Ramstedt K, Ekdahl K. Is the increase in notifications of Chlamydia trachomatis infections in Sweden the result of changes in prevalence, sampling frequency or diagnostic methods? Scand. J. Infect. Dis.34(1),28–34 (2002).
  MedlineGoogle Scholar
• 8  Eggleston E, Rogers SM, Turner CF et al.Chlamydia trachomatis infection among 15–35-year-olds in Baltimore, MD. Sex. Transm. Dis.38(8),743–749 (2011).
  MedlineGoogle Scholar
• 9  Fenton K, Copas A, Mitchell K et al. The acceptability of urinary LCR testing for Chlamydia trachomatis among participants in a probability sample survey of sexual attitudes and lifestyles. Sex. Transm. Infect.77(3),194–198 (2001).
  Medline CASGoogle Scholar
• 10  Hocking J, Willis J, Tabrizi S, Hellard M, Garland S, Fairley CK. A chlamydia prevalence survey of young women living in Melbourne, Victoria. Sex. Health3,235–240 (2006).
  MedlineGoogle Scholar
• 11  Goulet V, de Barbeyrac B, Raherison S et al. Prevalence of Chlamydia trachomatis : results from the first national population-based survey in France. Sex. Transm. Infect.86(4),263–270 (2010).
  Medline CASGoogle Scholar
• 12  Klovstad H, Grjibovski A, Aavitsland P. Population based study of genital Chlamydia trachomatis prevalence and associated factors in Norway: a cross sectional study. BMC Infect. Dis.12,150 (2012).
  MedlineGoogle Scholar
• 13  Datta SD, Torrone E, Kruszon-Moran D et al.Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999–2008. Sex. Transm. Dis.39(2),92–96 (2012).
  MedlineGoogle Scholar
• 14  Fine D, Thomas KK, Nakatsukasa-Ono W, Marrazzo J. Chlamydia positivity in women screened in family planning clinics: racial/ethnic differences and trends in the northwest U.S., 1997–2006. Public Health Rep.127(1),38–51 (2012).
  MedlineGoogle Scholar
• 15  Rao GG, Bacon L, Evans J et al. Prevalence of Neisseria gonorrhoeae infection in young subjects attending community clinics in South London. Sex. Transm. Infect.84(2),117–121 (2008).
  MedlineGoogle Scholar
• 16  Low N, Sterne JAC, Barlow D. Inequalities in rates of gonorrhoea and chlamydia between black ethnic groups in south east London: cross sectional study. Sex. Transm. Infect.77,15–20 (2001).
  Medline CASGoogle Scholar
• 17  Gotz HM, Veldhuijzen IK, Ossewaarde JM, de Zwart O, Richardus JH. Chlamydia trachomatis infections in multi-ethnic urban youth: a pilot combining STI health education and outreach testing in Rotterdam, Netherlands. Sex. Transm. Infect.82(2),148–152; discussion 152–143 (2006).
  Medline CASGoogle Scholar
• 18  Lewis D, Newton D, Guy R et al. The prevalence of Chlamydia trachomatis infection in Australia: a systematic review and meta-analysis. BMC Infect. Dis.12,113 (2012).
  MedlineGoogle Scholar
• 19  Annan NT, Sullivan AK, Nori A et al. Rectal chlamydia – a reservoir of undiagnosed infection in men who have sex with men. Sex. Transm. Infect.85(3),176–179 (2009).
  Medline CASGoogle Scholar
• 20  Centers for Disease Control and Prevention. Clinic-based testing for rectal and pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections by community-based organizations – five cities, United States, 2007. MMWR Morb. Mortal. Wkly Rep.58(26),716–719 (2009).
  MedlineGoogle Scholar
• 21  Kent CK, Chaw JK, Wong W et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin. Infect. Dis.41(1),67–74 (2005).
  MedlineGoogle Scholar
• 22  Peipert JF. Genital chlamydial infections. N. Engl. J. Med.349(25),2424–2430 (2003).
  Medline CASGoogle Scholar
• 23  Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J. Infect. Dis.201(Suppl. 2),S134–S155 (2010).
  MedlineGoogle Scholar
• 24  van Valkengoed IGM, Morre SA, van den Brule AJC, Meijer CJLM, Bouter LM, Boeke AJP. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes – implications for cost–effectiveness analyses. Int. J. Epidemiol.33,416–425 (2004).
  MedlineGoogle Scholar
• 25  Oakeshott P, Kerry S, Aghaizu A et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ340,c1642 (2010).
  MedlineGoogle Scholar
• 26  Wiesenfeld HC, Hillier SL, Krohn MA et al. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet. Gynecol.100(3),456–463 (2002).
  MedlineGoogle Scholar
• 27  Walker J, Fairley C, Bradshaw C et al.Chlamydia trachomatis incidence and re-infection among young women - behavioural and microbiological characteristics. PLoS One7(5),e37778 (2012).
  Medline CASGoogle Scholar
• 28  LaMontagne D, Baster K, Emmett L et al. Incidence and reinfection rates of genital chlamydia infection among women aged 16 to 24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group. Sex. Transm. Infect.83,282–303 (2007).
  MedlineGoogle Scholar
• 29  Batteiger BE, Tu W, Ofner S et al. Repeated Chlamydia trachomatis genital infections in adolescent women. J. Infect. Dis.201(1),42–51 (2010).
  MedlineGoogle Scholar
• 30  Hosenfeld CB, Workowski KA, Berman S et al. Repeat infection with chlamydia and gonorrhea among females: a systematic review of the literature. Sex. Transm. Dis.36(8),478–489 (2009).
  MedlineGoogle Scholar
• 31  Handsfield HH. Questionning azithromycin for chlamydial infection. Sex. Transm. Dis.38(11),1028–1029 (2011).
  MedlineGoogle Scholar
• 32  Horner P. The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection. Sex. Transm. Infect.82,340–343 (2006).
  Medline CASGoogle Scholar
• 33  Horner PJ. Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy. Sex. Transm. Infect.88(3),154–156 (2012).
  MedlineGoogle Scholar
• 34  Sandoz KM, Rockey DD. Antibiotic resistance in Chlamydiae. Future Microbiol.5(9),1427–1442 (2010).
  CASGoogle Scholar
• 35  Wang SA, Papp JR, Stamm WE, Peeling RW, Martin DH, Holmes KK. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis : a meeting report. J. Infect. Dis.191(6),917–923 (2005).
  MedlineGoogle Scholar
• 36  Golden MR, Whittington WL, Handsfield HH et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhoea or chlamydial infection. N. Engl. J. Med.352,676–685 (2005).
  Medline CASGoogle Scholar
• 37  Schwebke J, Rompalo A, Taylor S et al. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens – a randomized clinical trial. Clin. Infect. Dis.52(2),163–170 (2011).
  Medline CASGoogle Scholar
• 38  Tabrizi SN, Chen S, Borg AJ et al. Patient-administered tampon-collected genital cells in the assessment of Chlamydia trachomatis infection using polymerase chain reaction. Sex. Transm. Dis.23(6),494–497 (1996).
  Medline CASGoogle Scholar
• 39  Goldenberg S, Shoveller J, Koehoorn M, Ostry A. Barriers to STI testing among youth in a Canadian oil and gas community. Health Place14(4),718–729 (2008).
  MedlineGoogle Scholar
• 40  Kimmitt PT, Tabrizi SN, Crosatti M et al. Pilot study of the utility and acceptability of tampon sampling for the diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis infections by duplex realtime polymerase chain reaction in United Kingdom sex workers. Int. J. STD AIDS21(4),279–282 (2010).
  Medline CASGoogle Scholar
• 41  Bradshaw CS, Pierce LI, Tabrizi SN, Fairley CK, Garland SM. Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected sampling. Sex. Transm. Infect.81(1),53–58 (2005).
  Medline CASGoogle Scholar
• 42  CDC. Sexually transmitted diseases treatment guidelines, 2010. MMWR Morb. Mortal. Wkly Rep.59(RR-12),1–110 (2010).
  MedlineGoogle Scholar
• 43  European Centre for Disease Prevention and Control Guidance. Chlamydia Control in Europe. European Centre for Disease Prevention and Control, Sweden (2009).
  Google Scholar
• 44  Harris M, Bailey L, Bridges-Webb C, Ackermann E. Guidelines for Preventive Activities in General Practice (the Red Book) (8th Edition). Royal Australian College of General Practitioners, Australia (2012).
  Google Scholar
• 45  Low N, Cassell JA, Spencer B et al. Chlamydia control activities in Europe: cross-sectional survey. Eur. J. Pub. Health22(4),556–561 (2011).
  MedlineGoogle Scholar
• 46  Low N, Egger M. What should we do about screening for genital chlamydia? Int. J. Epidemiol.31,891–893 (2002).
  MedlineGoogle Scholar
• 47  Low N, Bender N, Nartey L, Shang A, Stephenson JM. Effectiveness of chlamydia screening: systematic review. Int. J. Epidemiol.38,435–448 (2009).
  MedlineGoogle Scholar
• 48  van den Broek IVF, van Bergen JEAM, Brouwers EEHG et al. Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation. BMJ345,e4316 (2012).
  MedlineGoogle Scholar
• 49  Jensen BL, Hoff G, Weismann K. A comparison of an enzyme immunoassay and cell culture for detection of Chlamydia trachomatis in genito-urinary specimens. Sex. Transm. Dis.15(2),123–126 (1988).
  Medline CASGoogle Scholar
• 50  Fletcher RH, Fletcher SW. Clinical Epidemiology: The Essentials. Lippincott, Williams and Wilkins, PA, USA (2005).
  Google Scholar
• 51  Hadgu A, Sternberg M. Reproducibility and specificity concerns associated with nucleic acid amplification tests for detecting Chlamydia trachomatis. Eur. J. Clin. Microbiol. Infect. Dis.28(1),9–15 (2009).
  Medline CASGoogle Scholar
• 52  Hadgu A. Issues in Chlamydia trachomatis testing by nucleic acid amplification test. J. Infect. Dis.193(9),1335–1336; author reply 1338–1339 (2006).
  MedlineGoogle Scholar
• 53  Hadgu A, Dendukuri N, Hilden J. Evaluation of nucleic acid amplification tests in the absence of a perfect gold-standard test: a review of the statistical and epidemiologic issues. Epidemiology16(5),604–612 (2005).
  MedlineGoogle Scholar
• 54  Schachter J, Stamm WE, Quinn TC. Discrepant analysis and screening for Chlamydia trachomatis. Lancet351(9097),217–218 (1998).
  Medline CASGoogle Scholar
• 55  Hilden J. Discrepant analysis – or behaviour? Lancet350(9082),902 (1997).
  Medline CASGoogle Scholar
• 56  Miller WC. Bias in discrepant analysis: when two wrongs don’t make a right. J. Clin. Epidemiol.51(3),219–231 (1998).
  Medline CASGoogle Scholar
• 57  Hadgu A, Dendukuri N, Wang L. Evaluation of screening tests for detecting Chlamydia trachomatis : bias associated with the patient-infected-status algorithm. Epidemiology23(1),72–82 (2012).
  MedlineGoogle Scholar
• 58  US FDA. Establishing the Performance Characteristics of In Vitro Diagnostic Devices for Chlamydia trachomatis and/or Neisseria gonorrhoea: Screening and Diagnostic Testing. US FDA, MD, USA (2011).
  Google Scholar
• 59  Van Der Pol B, Liesenfeld O, Williams JA et al. Performance of the cobas CT/NG test compared to the Aptima AC2 and Viper CTQ/GCQ assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J. Clin. Microbiol.50(7),2244–2249 (2012).
  Medline CASGoogle Scholar
• 60  Gronowski AM, Copper S, Baorto D, Murray PR. Reproducibility problems with the Abbott laboratories LCx assay for Chlamydia trachomatis and Neisseria gonorrhoeae. J. Clin. Microbiol.38(6),2416–2418 (2000).
  Medline CASGoogle Scholar
• 61  Culler EE, Caliendo AM, Nolte FS. Reproducibility of positive test results in the BDProbeTec ET system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J. Clin. Microbiol.41(8),3911–3914 (2003).
  Medline CASGoogle Scholar
• 62  Castriciano S, Luinstra K, Jang D et al. Accuracy of results obtained by performing a second ligase chain reaction assay and PCR analysis on urine samples with positive or near-cutoff results in the LCx test for Chlamydia trachomatis. J. Clin. Microbiol.40(7),2632–2634 (2002).
  Medline CASGoogle Scholar
• 63  Boel CHE, van Herk CMC, Berretty PJM, Onland GHW, van den Brule AJC. Evaluation of conventional and real-time PCR assays using two targets for confirmation of results of the COBAS AMPLICOR Chlamydia trachomatis/Neisseria gonorrhoeae test for detection of Neisseria gonorrhoeae in clinical samples. J. Clin. Microbiol.43(5),2231–2235 (2005).
  Medline CASGoogle Scholar
• 64  Verkooyen RP, Noordhoek GT, Klapper PE et al. Reliability of nucleic acid amplification methods for detection of Chlamydia trachomatis in urine: results of the first international collaborative quality control study among 96 laboratories. J. Clin. Microbiol.41(7),3013–3016 (2003).
  Medline CASGoogle Scholar
• 65  Schachter J, Chow JM, Howard H, Bolan G, Moncada J. Detection of Chlamydia trachomatis by nucleic acid amplification testing: our evaluation suggests that CDC-recommended approaches for confirmatory testing are ill-advised. J. Clin. Microbiol.44(7),2512–2517 (2006).
  Medline CASGoogle Scholar
• 66  Morre SA, Sillekens PT, Jacobs MV et al. Monitoring of Chlamydia trachomatis infections after antibiotic treatment using RNA detection by nucleic acid sequence based amplification. Mol. Pathol.51(3),149–154 (1998).
  Medline CASGoogle Scholar
• 67  Lewis N, Dube G, Carter C et al. Chlamydia and gonorrhoea contamination of clinic surfaces. Sex. Transm. Infect.88(6),418–421 (2012).
  MedlineGoogle Scholar
• 68  Renault CA, Israelski DM, Levy V, Fujikawa BK, Kellogg TA, Klausner JD. Time to clearance of Chlamydia trachomatis ribosomal RNA in women treated for chlamydial infection. Sex. Health8(1),69–73 (2011).
  MedlineGoogle Scholar
• 69  Dukers-Muijrers NHTM, Morre SA, Speksnijder A, van der Sande MAB, Hoebe CJPA. Chlamydia trachomatis test-of-cure cannot be based on a single highly sensitive laboratory test taken at least 3 weeks after treatment. PLoS One, 7(3),e34108 (2012).
  Medline CASGoogle Scholar
• 70  Ripa T, Nilsson P. A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use of PCR diagnostic tests. Eurosurveillance11(11),E061109.2. (2006).
  CASGoogle Scholar
• 71  Ripa T, Nilsson P. A Chlamydia trachomatis strain with a 377-bp deletion in the cryptic plasmid causing falsenegative nucleic acid amplification tests. Sex. Transm. Dis.34,255–256 (2007).
  MedlineGoogle Scholar
• 72  Soderblom T, Blaxhult A, Fredlund H, Herrmann B. Impact of a genetic variant of Chlamydia trachomatis on national detection rates in Sweden. Eurosurveillance11(12),E061207.1. (2006).
  CASGoogle Scholar
• 73  Kangas I, Andersen B, Olsen F, Moller J, Ostergaard L. Psychosocial impact of Chlamydia trachomatis testing in general practice. Br. J. Gen. Pract.56,587–593 (2006).
  MedlineGoogle Scholar
• 74  France C, Thomas K, Slack R, James N. Psychosocial impacts of chlamydia testing are important. BMJ322,1245 (2001).
  Medline CASGoogle Scholar
• 75  Duncan B, Hart G, Scoular A, Bigrigg A. Qualitative analysis of psychosocial impact of diagnosis of Chlamydia trachomatis : implication for screening. BMJ322,195–199 (2001).
  Medline CASGoogle Scholar
• 76  Pavlin N, Gunn JM, Parker R, Fairley CK, Hocking J. Implementing chlamydia screening: what do women think? A systematic review of the literature. BMC Public Health6,221–231 (2006).
  MedlineGoogle Scholar
• 77  Pasternack R, Vuorinen P, Miettinen A. Evaluation of the Gen-Probe Chlamydia trachomatis transcription-mediated amplification assay with urine specimens from women. J. Clin. Microbiol.35(3),676–678 (1997).
  Medline CASGoogle Scholar
• 78  Ostergaard L, Moller JK, Andersen B, Olesen F. Diagnosis of urogenital Chlamydia trachomatis infection in women based on mailed samples obtained at home: multipractice comparative study. BMJ313(7066),1186–1189 (1996).
  Medline CASGoogle Scholar
• 79  Chernesky MA, Lee H, Schachter J et al. Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay. J. Infect. Dis.170(5),1308–1311 (1994).
  Medline CASGoogle Scholar
• 80  Chernesky MA, Jang D, Lee H et al. Diagnosis of Chlamydia trachomatis infections in men and women by testing first-void urine by ligase chain reaction. J. Clin. Microbiol.32(11),2682–2685 (1994).
  Medline CASGoogle Scholar
• 81  Bianchi A, Scieux C, Brunat N et al. An evaluation of the polymerase chain reaction amplicor Chlamydia trachomatis in male urine and female urogenital specimens. Sex. Transm. Dis.21(4),196–200 (1994).
  Medline CASGoogle Scholar
• 82  Williams J, van der Pol B, Rosenberger J, Ott M. Evaluation of the UriSwab sponge collection device for the detection of Chlamydia trachomatis in urine. Presented at: International Society of STD Research. London, UK, July 2009.
  Google Scholar
• 83  Garrow SC, Smith DW, Harnett GB. The diagnosis of chlamydia, gonorrhoea and trichomonas infections by self obtained low vaginal swabs , in remote northern Australian clinical practice. Sex. Transm. Infect.78(4),278–281 (2002).
  Medline CASGoogle Scholar
• 84  Knox J, Tabrizi SN, Miller P et al. Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas. Sex. Transm. Dis.29(11),647–654 (2002).
  MedlineGoogle Scholar
• 85  Schachter J, McCormack WM, Chernesky MA et al. Vaginal swabs are appropriate specimens for diagnosis of genital chlamydia tract infection with Chlamydia trachomatis. J. Clin. Microbiol.41(8),3784–3789 (2003).
  MedlineGoogle Scholar
• 86  Hsieh Y-H, Howell MR, Gaydos JC, McKee KT, Quinn TC, Gaydos CA. Preference among female army recruits for use of self-administered vaginal swabs or urine to screen for Chlamydia trachomatis genital infections. Sex. Transm. Dis.30(10),769–773 (2003).
  MedlineGoogle Scholar
• 87  Chernesky MA, Hook EW, 3rd, Martin DH et al. Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections. Sex. Transm. Dis.32(12),729–733 (2005).
  MedlineGoogle Scholar
• 88  Schachter J, Chernesky MA, Willis DE et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae : results from a multicenter evaluation of the APTIMA assays for both infections. Sex. Transm. Dis.32(12),725–728 (2005).
  MedlineGoogle Scholar
• 89  Chandeying V, Lamlertkittikul S, Skov S. A comparison of first-void urine, self-administered low vaginal swab, self-inserted tampon, and endocervical swab using PCR tests for the detection of infection with Chlamydia trachomatis. Sex. Health1(1),51–54 (2004).
  Medline CASGoogle Scholar
• 90  Wiesenfeld HC, Lowry DL, Heine RP et al. Self-collection of vaginal swabs for the detection of chlamydia, gonorrhea, and trichomoniasis: opportunity to encourage sexually transmitted disease testing among adolescents. Sex. Transm. Dis.28(6),321–325 (2001).
  Medline CASGoogle Scholar
• 91  Doshi JS, Power J, Allen E. Acceptability of chlamydia screening using self-taken vaginal swabs. Int. J. STD AIDS19(8),507–509 (2008).
  Medline CASGoogle Scholar
• 92  Hoebe CJPA, Rademaker CW, Brouwers EEHG, ter Waarbeek HLG, van Bergen JEAM. Acceptability of self-taken vaginal swabs and first-catch urine samples for the diagnosis of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae with an amplified DNA assay in young women attending a public health sexually transmitted disease clinic. Sex. Transm. Dis.33(8),491–495 (2006).
  MedlineGoogle Scholar
• 93  Alary M, Poulin C, Bouchard C et al. Evaluation of a modified sanitary napkin as a sample self-collection device for the detection of genital chlamydial infection in women. J. Clin. Microbiol.39(7),2508–2512 (2001).
  Medline CASGoogle Scholar
• 94  Tabrizi SN, Paterson B, Fairley CK, Bowden FJ, Garland SM. A self-administered technique for the detection of sexually transmitted diseases in remote communities. J. Infect. Dis.176(1),289–292 (1997).
  Medline CASGoogle Scholar
• 95  Bowden FJ, Paterson BA, Tabrizi SN, Fairley CK, Garland SM. Using self-administered tampons to diagnose STDs. AIDS Patient Care STDs12(1),29–32 (1998).
  Medline CASGoogle Scholar
• 96  Tabrizi SN, Paterson BA, Fairley CK, Bowden FJ, Garland SM. Comparison of tampon and urine as self-administered methods of specimen collection in the detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in women. Int. J. STD AIDS9(6),347–349 (1998).
  Medline CASGoogle Scholar
• 97  Tabrizi SN, Fairley CK, Cehn S et al. Evaluation of patient-administered tampon specimens for Chlamydia trachomatis and Neisseria gonorrhoeae. Sex. Transm. Dis.27(3),133–137 (2000).
  Medline CASGoogle Scholar
• 98  Garland SM, Tabrizi SN. Diagnosis of sexually transmitted infections (STI) using self-collected non-invasive specimens. Sex. Health1(2),121–126 (2004).
  MedlineGoogle Scholar
• 99  Tabrizi S, Chen S, Fairley C et al. Tampon-collected genital cells in the detection of Chlamydia trachomatis by polymerase chain reaction. J. Infect. Dis.168(3),796–797 (1993).
  Medline CASGoogle Scholar
• 100  Smith BL, Cummings MC, Benes S, McCormack WM. Evaluation of vaginal tampons for collection of specimens for detection of chlamydial infection. Sex. Transm. Dis.23(2),127–130 (1996).
  Medline CASGoogle Scholar
• 101  Chai SJ, Aumakhan B, Barnes M et al. Internet-based screening for sexually transmitted infections to reach nonclinic populations in the community: risk factors for infection in men. Sex. Transm. Dis.37(12),756–763 (2010).
  MedlineGoogle Scholar
• 102  Alexander S, Ison C, Parry J et al. Self-taken pharyngeal and rectal swabs are appropriate for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in asymptomatic men who have sex with men. Sex. Transm. Infect.84(6),488–492 (2008).
  Medline CASGoogle Scholar
• 103  Moncada J, Schachter J, Liska S, Shayevich C, Klausner JD. Evaluation of self-collected glans and rectal swabs from men who have sex with men for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of nucleic acid amplification tests. J. Clin. Microbiol.47(6),1657–1662 (2009).
  Medline CASGoogle Scholar
• 104  van der Helm JJ, Hoebe CJPA, van Rooijen MS et al. High performance and acceptability of self-collected rectal swabs for diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in men who have sex with men and women. Sex. Transm. Dis.36(8),493–497 (2009).
  MedlineGoogle Scholar
• 105  Twin J, Moore EE, Garland SM et al.Chlamydia trachomatis genotypes among men who have sex with men in Australia. Sex. Transm. Dis.38(4),279–285 (2011).
  MedlineGoogle Scholar
• 106  Freeman A, Bernstein K, Kohn R, Philip S, Rauch L, Klausner J. Evaluation of self-collected versus clinician-collected swabs for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae pharyngeal infection among men who have sex with men. Sex. Transm. Dis.38(11),1036–1039 (2011).
  MedlineGoogle Scholar
• 107  Tabrizi S. Diagnosis of Chlamydia trachomatis using self collected non-invasive specimens – the Australian experience. Microbiol. Aust.28(1),10–12 (2007).
  Google Scholar
• 108  Cook RL, Hutchison SL, Ostergaard L, Braithwaite RS, Ness RB. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann. Intern. Med.142(11),914–925 (2005).
  MedlineGoogle Scholar
• 109  Marrazzo JM, Scholes D. Acceptability of urine-based screening for Chlamydia trachomatis in asymptomatic young men: a systematic review. Sex. Transm. Dis.35(11 Suppl.),S28–S33 (2008).
  MedlineGoogle Scholar
• 110  Serlin M, Shafer M-A, Tebb K et al. What sexually transmitted disease screening method does the adolescent prefer? Adolescents’ attitudes toward first-void urine, self-collected vaginal swab, and pelvic examination. Arch. Pediatr. Adolesc. Med.156(6),588–591 (2002).
  MedlineGoogle Scholar
• 111  Morre SA, van Valkengoed IG, de Jong A et al. Mailed, home-obtained urine specimens: a reliable screening approach for detecting asymptomatic Chlamydia trachomatis infections. J. Clin. Microbiol.37(4),976–980 (1999).
  Medline CASGoogle Scholar
• 112  van Dommelen L, Dukers-Muijrers N, van Tiel FH, Brouwers EEHG, Hoebe CJPA. Evaluation of one-sample testing of self-obtained vaginal swabs and first catch urine samples separately and in combination for the detection of Chlamydia trachomatis by two amplified DNA assays in women visiting a sexually transmitted disease clinic. Sex. Transm. Dis.38(6),533–535 (2011).
  MedlineGoogle Scholar
• 113  Skidmore S, Horner P, Herring A et al. Vulvovaginal-swab or first-catch urine specimen to detect Chlamydia trachomatis in women in a community setting? J. Clin. Microbiol.44(12),4389–4394 (2006).
  MedlineGoogle Scholar
• 114  Hook EW 3rd, Smith K, Mullen C et al. Diagnosis of genitourinary Chlamydia trachomatis infections by using the ligase chain reaction on patient-obtained vaginal swabs. J. Clin. Microbiol.35(8),2133–2135 (1997).
  MedlineGoogle Scholar
• 115  Geisler WM. Diagnosis and management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: summary of evidence reviewed for the 2010 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin. Infect. Dis.53(Suppl. 3),S92–S98 (2011).
  MedlineGoogle Scholar
• 116  Gaydos CA, Farshy C, Barnes M et al. Can mailed swab samples be dry-shipped for the detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by nucleic acid amplification tests? Diagn. Microbiol. Infect. Dis.73(1),16–20 (2012).
  MedlineGoogle Scholar
• 117  Alexander S, Martin I, Ison C. Confirming the Chlamydia trachomatis status of referred rectal specimens. Sex. Transm. Infect.83(4),327–329 (2007).
  MedlineGoogle Scholar
• 118  Schachter J, Moncada J, Liska S, Shayevich C, Klausner JD. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex. Transm. Dis.35(7),637–642 (2008).
  Medline CASGoogle Scholar
• 119  Tipple C, Hill SC, Smith A. Is screening for pharyngeal Chlamydia trachomatis warranted in high-risk groups? Int. J. STD AIDS21(11),770–771 (2010).
  Medline CASGoogle Scholar
• 120  Peters RPH, Nijsten N, Mutsaers J, Jansen CL, Morre SA, van Leeuwen AP. Screening of oropharynx and anorectum increases prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infection in female STD clinic visitors. Sex. Transm. Dis.38(9),783–787 (2011).
  MedlineGoogle Scholar
• 121  Royal Australasian College of Physicians. Sexually Transmitted Infection Testing Guidelines for Men Who Have Sex With Men 2010. Royal Australasian College of Physicians, New Zealand (2010).
  Google Scholar
• 122  Ostergaard L, Andersen B, Olesen F, Moller JK. Efficacy of home sampling for screening of Chlamydia trachomatis : randomised study. BMJ317(7150),26–27 (1998).
  Medline CASGoogle Scholar
• 123  Pannekoek Y, Westenberg SM, de Vries J et al. PCR assessment of Chlamydia trachomatis infection of semen specimens processed for artificial insemination. J. Clin. Microbiol.38(10),3763–3767 (2000).
  Medline CASGoogle Scholar
• 124  Rodger A, Hocking J, Warren R, Snow J, Aboagye-Kwarteng T, Crofts N. Prevalence of genital Chlamydia trachomatis in male clients of female sex workers in Melbourne. Venereology12(4),129–132 (1999).
  Google Scholar
• 125  Tabrizi S, Skov S, Chandeying V, Norpech J, Garland S. Prevalence of sexually transmitted infections among clients of female commercial sex workers in Thailand. Sex. Transm. Dis.27(6),358–362 (2000).
  Medline CASGoogle Scholar
• 126  Shafer M-A, Moncada J, Boyer CB, Betsinger K, Flinn SD, Schachter J. Comparing first-void urine specimens, self-collected vaginal swabs, and endocervical specimens to detect Chlamydia trachomatis and Neisseria gonorrhoeae by a nucleic acid amplification test. J. Clin. Microbiol.41(9),4395–4399 (2003).
  MedlineGoogle Scholar
• 127  Richardson E, Sellors JW, Mackinnon S et al. Prevalence of Chlamydia trachomatis infections and specimen collection preference among women, using self-collected vaginal swabs in community settings. Sex. Transm. Dis.30(12),880–885 (2003).
  MedlineGoogle Scholar
• 128  Tilson EC, Sanchez V, Ford CL et al. Barriers to asymptomatic screening and other STD services for adolescents and young adults: focus group discussions. BMC Public Health4,21 (2004).
  MedlineGoogle Scholar
• 129  Warr D, Hillier L. “That’s the problem with living in a small town”: privacy and sexual health issues for young rural people. Aust. J. Rural Health5(3),132–139 (1997).
  Medline CASGoogle Scholar
• 130  Wang LY, Burstein GR, Cohen DA. An economic evaluation of a school-based sexually transmitted disease screening program. Sex. Transm. Dis.29(12),737–745 (2002).
  MedlineGoogle Scholar
• 131  Nsuami M, Cohen DA. Participation in a school-based sexually transmitted disease screening program. Sex. Transm. Dis.27(8),473–479 (2000).
  Medline CASGoogle Scholar
• 132  Burstein GR, Waterfield G, Joffe A, Zenilman JM, Quinn TC, Gaydos CA. Screening for gonorrhea and chlamydia by DNA amplification in adolescents attending middle school health centers. Opportunity for early intervention. Sex. Transm. Dis.25(8),395–402 (1998).
  Medline CASGoogle Scholar
• 133  Braun RA, Provost JM. Bridging the gap: using school-based health services to improve chlamydia screening among young women. Am. J. Public Health100(9),1624–1629 (2010).
  MedlineGoogle Scholar
• 134  Bowden FJ, O’Keefe EJ, Primrose R, Currie MJ. Sexually transmitted infections, blood-borne viruses and risk behaviour in an Australian senior high school population – the SHLiRP study. Sex. Health2(4),229–236 (2005).
  MedlineGoogle Scholar
• 135  Debattista J, Martin P, Jamieson J et al. Detection of Chlamydia trachomatis in an Australian high school student population. Sex. Transm. Infect.78(3),194–197 (2002).
  Medline CASGoogle Scholar
• 136  Barry PM, Scott KC, McCright J et al. Stay in school? Results of a sexually transmitted diseases screening program in San Francisco high schools-2007. Sex. Transm. Dis.35(6),550–552 (2008).
  MedlineGoogle Scholar
• 137  Kent CK, Branzuela A, Fischer L, Bascom T, Klausner JD. Chlamydia and gonorrhea screening in San Francisco high schools. Sex. Transm. Dis.29(7),373–375 (2002).
  MedlineGoogle Scholar
• 138  Asbel LE, Newbern EC, Salmon M, Spain CV, Goldberg M. School-based screening for Chlamydia trachomatis and Neisseria gonorrhoeae among Philadelphia public high school students. Sex. Transm. Dis.33(10),614–620 (2006).
  MedlineGoogle Scholar
• 139  Cohen DA, Nsuami M, Etame RB et al. A school-based chlamydia control program using DNA amplification technology. Pediatrics101(1),E1 (1998).
  Medline CASGoogle Scholar
• 140  Joffe A, Rietmeijer CA, Chung S-E et al. Screening asymptomatic adolescent men for Chlamydia trachomatis in school-based health centers using urine-based nucleic acid amplification tests. Sex. Transm. Dis.35(Suppl. 11),S19–s23 (2008).
  MedlineGoogle Scholar
• 141  Gaydos CA, Hsieh YH, Galbraith JS, Barnes M, Waterfield G, Stanton B. Focus-on-Teens, sexual risk-reduction intervention for high-school adolescents: impact on knowledge, change of risk-behaviours, and prevalence of sexually transmitted diseases. Int. J. STD AIDS19(10),704–710 (2008).
  Medline CASGoogle Scholar
• 142  Gold J, Hocking J, Hellard M. The feasibility of recruiting young men in rural areas from community football clubs for STI screening. Aust. NZ J. Public Health31(3),243–246 (2007).
  MedlineGoogle Scholar
• 143  Kong FYS, Hocking JS, Link CK, Chen MY, Hellard ME. Sex and sport: chlamydia screening in rural sporting clubs. BMC Infect. Dis.9,73 (2009).
  MedlineGoogle Scholar
• 144  Debattista J, Clementson C, Mason D et al. Screening for Neisseria gonorrhoeae and Chlamydia trachomatis at entertainment venues among men who have sex with men. Sex. Transm. Dis.29(4),216–221 (2002).
  MedlineGoogle Scholar
• 145  Debattista J, Dwyer J, Orth D, Lister G, Patten J. Community screening for Neisseria gonorrhoeae and Chlamydia trachomatis among patrons of sex-on-premises venues: two years later. Venereology13(3),105–109 (2000).
  Google Scholar
• 146  Lister N, Smith A, Tabrizi S et al. Screening for Neisseria gonorrhoeae and Chlamydia trachomatis in men who have sex with men at male-only saunas. Sex. Transm. Dis.30(12),886–889 (2003).
  Medline CASGoogle Scholar
• 147  Lambert NL, Fisher M, Imrie J et al. Community based syphilis screening: feasibility, acceptability, and effectiveness in case finding. Sex. Transm. Infect.81(3),213–216 (2005).
  Medline CASGoogle Scholar
• 148  Mayer KH, Ducharme R, Zaller ND et al. Unprotected sex, underestimated risk, undiagnosed HIV and sexually transmitted diseases among men who have sex with men accessing testing services in a New England bathhouse. J. Acquir. Immune Defic. Syndr.59(2),194–198 (2012).
  MedlineGoogle Scholar
• 149  Buhrer-Skinner M, Muller R, Menon A, Gordon R. Novel approach to an effective community-based chlamydia screening program within the routine operation of a primary healthcare service. Sex. Health6(1),51–56 (2009).
  MedlineGoogle Scholar
• 150  Martin L, Freedman E, Burton L et al. The C-project: use of self-collection kits to screen for Chlamydia trachomatis in young people in a community-based health promotion project. Sex. Health6(2),157–162 (2009).
  MedlineGoogle Scholar
• 151  Cwikel JG, Lazer T, Press F, Lazer S. Sexually transmissible infections among female sex workers: an international review with an emphasis on hard-to-access populations. Sex. Health5(1),9–16 (2008).
  MedlineGoogle Scholar
• 152  Morton AN, Wakefield T, Tabrizi SN, Garland SM, Fairley CK. An outreach programme for sexually transmitted infection screening in street sex workers using self-administered samples. Int. J. STD AIDS10(11),741–743 (1999).
  Medline CASGoogle Scholar
• 153  Mak RP, Van Renterghem L, Traen A. Chlamydia trachomatis in female sex workers in Belgium: 1998–2003. Sex. Transm. Infect.81(1),89–90 (2005).
  Medline CASGoogle Scholar
• 154  Macauley S, Creighton S. Testing commercial sex workers for chlamydia and gonorrhoea on outreach. Sex. Transm. Infect.85(3),231–232 (2009).
  Medline CASGoogle Scholar
• 155  Van Leeuwen JM, Rietmeijer CA, LeRoux T, White R, Petersen J. Reaching homeless youths for Chlamydia trachomatis and Neisseria gonorrhoeae screening in Denver, Colorado. Sex. Transm. Infect.78(5),357–359 (2002).
  Medline CASGoogle Scholar
• 156  Auerswald CL, Sugano E, Ellen JM, Klausner JD. Street-based STD testing and treatment of homeless youth are feasible, acceptable and effective. J. Adolesc. Health38(3),208–212 (2006).
  MedlineGoogle Scholar
• 157  Grimley DM, Annang L, Lewis I et al. Sexually transmitted infections among urban shelter clients. Sex. Transm. Dis.33(11),666–669 (2006).
  MedlineGoogle Scholar
• 158  Bradshaw CS, Pierce LI, Tabrizi SN, Fairley CK, Garland SM. Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected sampling. Sex. Transm. Infect.81(1),53–58 (2005).
  Medline CASGoogle Scholar
• 159  Peterman TA, Newman DR, Goldberg M et al. Screening male prisoners for Chlamydia trachomatis : impact on test positivity among women from their neighborhoods who were tested in family planning clinics. Sex. Transm. Dis.36(7),425–429 (2009).
  MedlineGoogle Scholar
• 160  Mertz KJ, Schwebke JR, Gaydos CA, Beidinger HA, Tulloch SD, Levine WC. Screening women in jails for chlamydial and gonococcal infection using urine tests: feasibility, acceptability, prevalence, and treatment rates. Sex. Transm. Dis.29(5),271–276 (2002).
  MedlineGoogle Scholar
• 161  Davies SC, Karagiannis T, Headon V, Wiig R, Duffy J. Prevalence of genital chlamydial infection among a community sample of young international backpackers in Sydney, Australia. Int. J. STD AIDS22(3),160–164 (2011).
  Medline CASGoogle Scholar
• 162  Bloom MS, Hu Z, Gaydos JC, Brundage JF, Tobler SK. Incidence rates of pelvic inflammatory disease diagnoses among Army and Navy recruits potential impacts of chlamydia screening policies. Am. J. Prev. Med.34(6),471–477 (2008).
  MedlineGoogle Scholar
• 163  Greenland KE, Op de Coul ELM, van Bergen JEAM et al. Acceptability of the internet-based chlamydia screening implementation in The Netherlands and insights into nonresponse. Sex. Transm. Dis.38(6),467–474 (2011).
  MedlineGoogle Scholar
• 164  Gaydos CA, Dwyer K, Barnes M et al. Internet-based screening for Chlamydia trachomatis to reach non-clinic populations with mailed self-administered vaginal swabs. Sex. Transm. Dis.33(7),451–457 (2006).
  MedlineGoogle Scholar
• 165  Masek BJ, Arora N, Quinn N et al. Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an internet-based screening program. J. Clin. Microbiol.47(6),1663–1667 (2009).
  Medline CASGoogle Scholar
• 166  Gaydos CA, Barnes M, Aumakhan B et al.Chlamydia trachomatis age-specific prevalence in women who used an internet-based self-screening program compared to women who were screened in family planning clinics. Sex. Transm. Dis.38(2),74–78 (2011).
  MedlineGoogle Scholar
• 167  Jenkins WD, Rabins C, Barnes M, Agreda P, Gaydos C. Use of the internet and self-collected samples as a sexually transmissible infection intervention in rural Illinois communities. Sex. Health8(1),79–85 (2011).
  MedlineGoogle Scholar
• 168  Novak D, Novak M. Use of the internet for home testing for Chlamydia trachomatis in Sweden: who are the users? Int. J. STD AIDS23(2),83–87 (2012).
  Medline CASGoogle Scholar
• 169  Shih SL, Graseck AS, Secura GM, Peipert JF. Screening for sexually transmitted infections at home or in the clinic? Curr. Opin. Infect. Dis.24(1),78–84 (2011).
  MedlineGoogle Scholar
• 170  Baraitser P, Pearce V, Holmes J, Horne N, Boynton PM. Chlamydia testing in community pharmacies: evaluation of a feasibility pilot in south east London. Qual. Saf. Health Care16(4),303–307 (2007).
  Medline CASGoogle Scholar
• 171  Brabin L, Thomas G, Hopkins M, O’Brien K, Roberts SA. Delivery of chlamydia screening to young women requesting emergency hormonal contraception at pharmacies in Manchester, UK: a prospective study. BMC Womens Health9,7 (2009).
  MedlineGoogle Scholar
• 172  Anderson C, Thornley T. A pharmacy-based private chlamydia screening programme: results from the first 2 years of screening and treatment. Int.J. Clin. Pharm.33(1),88–91 (2011).
  MedlineGoogle Scholar
• 173  Health Protection Agency. Annual Report of the National Chlamydia Screening Programme in England 2006/7. National Chlamydia Screening Programme, UK (2007).
  Google Scholar
• 174  Department of Health. Boots Selected to Provide Free Chlamydia Screening for 16–24 Year Olds Across the Capital. Department of Health, UK (2005).
  Google Scholar
• 175  Sexual Health Society of Victoria. National Management Guidelines for Sexually Transmissible Infections. Sexual Health Society of Victoria, Australia (2008).
  Google Scholar
• 176  Guy R, Hocking J, Low N et al. Interventions to increase rescreening for repeat chlamydial infection. Sex. Transm. Dis.39(2),136–146 (2012).
  MedlineGoogle Scholar
• 177  Mukenge-Tshibaka L, Alary M, Lowndes CM et al. Syndromic versus laboratory-based diagnosis of cervical infections among female sex workers in Benin: implications of nonattendance for return visits. Sex. Transm. Dis.29(6),324–330 (2002).
  MedlineGoogle Scholar
• 178  Vickerman P, Watts C, Alary M, Mabey D, Peeling RW. Sensitivity requirements for the point of care diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in women. Sex. Transm. Infect.79(5),363–367 (2003).
  Medline CASGoogle Scholar
• 179  Guy R, Ward JS, Smith KS et al. The impact of sexually transmissible infection programs in remote Aboriginal communities in Australia: a systematic review. Sex. Health9(3),205–212 (2012).
  MedlineGoogle Scholar
• 180  Gift TL, Pate MS, Hook EW 3rd, Kassler WJ. The rapid test paradox: when fewer cases detected lead to more cases treated: a decision analysis of tests for Chlamydia trachomatis.Sex. Transm. Dis.26(4),232–240 (1999).
  Medline CASGoogle Scholar
• 181  Hislop J, Quayyum Z, Flett G, Boachie C, Fraser C, Mowatt G. Systematic review of the clinical effectiveness and cost–effectiveness of rapid point-of-care tests for the detection of genital chlamydia infection in women and men. Health Technol. Assess.14(29),1–97, iii–iv (2010).
  CASGoogle Scholar
• 182  Huang W, Gaydos CA, Barnes MR, Jett-Goheen M, Blake DR. Comparative effectiveness of a rapid point-of-care test for detection of Chlamydia trachomatis among women in a clinical setting. Sex. Transm. Infect. doi:10.1136/sextrans-2011-050355 (2012) (Epub ahead of print).
  MedlineGoogle Scholar
• 183  Bowden FJ. Reappraising the value of urine leukocyte esterase testing in the age of nucleic acid amplification. Sex. Transm. Dis.25(6),322–326 (1998).
  Medline CASGoogle Scholar
• 184  van Dommelen L, van Tiel FH, Ouburg S et al. Alarmingly poor performance in Chlamydia trachomatis point-of-care testing. Sex. Transm. Infect.86(5),355–359 (2010).
  MedlineGoogle Scholar
• 185  Nadala E-C, Goh BT, Magbanua J-P et al. Performance evaluation of a new rapid urine test for chlamydia in men: prospective cohort study. BMJ339,b2655 (2009).
  MedlineGoogle Scholar
• 186  GeneXpert Technology: a look to the future. Presented at: Association for Molecular Pathology Annual Meeting, Grapevine, TX, USA, 17–19 November 2011.
  Google Scholar
• 187  Goldenberg SD, Finn J, Sedudzi E, White JA, Tong CYW. Performance of the GeneXpert CT/NG assay compared to that of the Aptima AC2 Assay for detection of rectal Chlamydia trachomatis and Neisseria gonorrhoeae by use of residual aptima samples. J. Clin. Microbiol.50(12),3867–3869 (2012).
  Medline CASGoogle Scholar
• 188  Peeling RW. Applying new technologies for diagnosing sexually transmitted infections in resource-poor settings. Sex. Transm. Infect.87(Suppl. 2),ii28–ii30 (2011).
  MedlineGoogle Scholar
• 189  Piepenburg O, Williams CH, Stemple DL, Armes NA. DNA detection using recombination proteins. PLoS Biol.4(7),e204 (2006).
  MedlineGoogle Scholar
• 190  Zhang Y, Agreda P, Kelley S, Gaydos C, Geddes CD. Development of a microwave-accelerated metal-enhanced fluorescence 40 second, <100 cfu/ml point of care assay for the detection of Chlamydia trachomatis. IEEE Trans. Biomed. Eng.58(3),781–784 (2011).
  MedlineGoogle Scholar
• 191  Christerson L, Ruettger A, Gravningen K, Ehricht R, Sachse K, Herrmann B. High-resolution genotyping of Chlamydia trachomatis by use of a novel multilocus typing DNA microarray. J. Clin. Microbiol.49(8),2838–2843 (2011).
  MedlineGoogle Scholar
• 192  Gravningen K, Christerson L, Furberg A-S et al. Multilocus sequence typing of genital Chlamydia trachomatis in Norway reveals multiple new sequence types and a large genetic diversity. PLoS One7(3),e34452 (2012).
  Medline CASGoogle Scholar
• 193  Stevens MP, Tabrizi SN, Muller R, Krause V, Garland SM. Characterization of Chlamydia trachomatis omp1 genotypes detected in eye swab samples from remote Australian communities. J. Clin. Microbiol.42(6),2501–2507 (2004).
  Medline CASGoogle Scholar
• 194  Geisler WM, Black CM, Bandea CI, Morrison SG. Chlamydia trachomatis OmpA genotyping as a tool for studying the natural history of genital chlamydial infection. Sex. Transm. Infect.84(7),541–544; discussion 544–545 (2008).
  Medline CASGoogle Scholar
• 195  Wylie JL, Cabral T, Jolly AM. Identification of networks of sexually transmitted infection: a molecular, geographic, and social network analysis. J. Infect. Dis.191(6),899–906 (2005).
  MedlineGoogle Scholar
• 196  Eckert LO, Suchland RJ, Hawes SE, Stamm WE. Quantitative Chlamydia trachomatis cultures: correlation of chlamydial inclusion-forming units with serovar, age, sex, and race. J. Infect. Dis.182(2),540–544 (2000).
  Medline CASGoogle Scholar
• 197  Rogers SM, Miller WC, Turner CF et al. Concordance of Chlamydia trachomatis infections within sexual partnerships. Sex. Transm. Infect.84(1),23–28 (2007).
  MedlineGoogle Scholar
• 198  Geisler WM, Suchland RJ, Whittington WL, Stamm WE. Quantitative culture of Chlamydia trachomatis : relationship of inclusion-forming units produced in culture to clinical manifestations and acute inflammation in urogenital disease. J. Infect. Dis.184(10),1350–1354 (2001).
  Medline CASGoogle Scholar
• 199  Batteiger BE, Xu F, Johnson RE, Rekart ML. Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies. J. Infect. Dis.201(Suppl. 2),S178–S189 (2010).
  Medline CASGoogle Scholar
• 200  Gomes JP, Borrego MJ, Atik B et al. Correlating Chlamydia trachomatis infectious load with urogenital ecological success and disease pathogenesis. Microbes Infect.8(1),16–26 (2006).
  Medline CASGoogle Scholar
• 201  Molano M, Meijer CJLM, Weiderpass E et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J. Infect. Dis.191,907–916 (2005).
  MedlineGoogle Scholar
• 202  Gray RT, Beagley KW, Timms P, Wilson DP. Modeling the impact of potential vaccines on epidemics of sexually transmitted Chlamydia trachomatis infection. J. Infect. Dis.199(11),1680–1688 (2009).
  MedlineGoogle Scholar
• 203  Jones RB, Vanderpol B, Martin DH, Shepard MK. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics. J. Infect. Dis.162(6),1309–1315 (1990).
  Medline CASGoogle Scholar
• 204  Lefevre JC, Lepargneur JP. Comparative in vitro susceptibility of a tetracycline-resistant Chlamydia trachomatis strain isolated in Toulouse (France). Sex. Transm. Dis.25(7),350–352 (1998).
  Medline CASGoogle Scholar
• 205  Mourad A, Sweet RL, Sugg N, Schachter J. Relative resistance to erythromycin in Chlamydia trachomatis. Antimicrob. Agents Chemother.18(5),696–698 (1980).
  Medline CASGoogle Scholar
• 206  Somani J, Bhullar VB, Workowski KA, Farshy CE, Black CM. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J. Infect. Dis.181(4),1421–1427 (2000).
  Medline CASGoogle Scholar
• 207  Bhengraj AR, Vardhan H, Srivastava P, Salhan S, Mittal A. Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India. Chemotherapy56(5),371–377 (2010).
  Medline CASGoogle Scholar
• 208  Shkarupeta MM, Lazarev VN, Akopian TA, Afrikanova TS, Govorun VM. Analysis of antibiotic resistance markers in Chlamydia trachomatis clinical isolates obtained after ineffective antibiotic therapy. Bull. Exp. Biol. Med.143(6),713–717 (2007).
  Medline CASGoogle Scholar
• 209  Zhu H, Wang HP, Jiang Y, Hou SP, Liu YJ, Liu QZ. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in Chlamydia trachomatis strains selected in vitro by macrolide passage. Andrologia42(4),274–280 (2010).
  Medline CASGoogle Scholar
• 210  Misyurina OY, Chipitsyna EV, Finashutina YP et al. Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides. Antimicrob. Agents Chemother.48(4),1347–1349 (2004).
  Medline CASGoogle Scholar
• 301  NHS. National Chlamydia Screening Programme. www.chlamydiascreening.nhs.uk
  Google Scholar
• 302  Australian Chlamydia Control Effectiveness Pilot. www.accept.org.au
  Google Scholar
• 303  I want the Kit. John Hopkin’s University. www.iwantthekit.org
  Google Scholar
• 304  WHO. Mapping the landscape of diagnostics for sexually transmitted infections. www.who.int/tdr/publications/documents/mapping-landscape-sti.pdf
  Google Scholar
• 305  Cepheid Xpert® CT/NG Product Information. www.cepheid.com/product-catalog/clinical-ivd-tests/xpert-ctng
  Google Scholar
• 306  Smittskyddsinstitutet (SMI). Chlamydia Infection. www.smittskyddsinstitutet.se/in-english/statistics/chlamydia-infection
  Google Scholar
• 307  Statens Serum Institut. www.ssi.dk/data
  Google Scholar
• 308  CDC WONDER Online Database. www.wonder.cdc.gov/std-v2008.html
  Google Scholar
• 309  Public Health Agency of Canada. Reported cases and rates of chlamydia by province/territory and sex, 1991 to 2009. www.phac-aspc.gc.ca/std-mts/sti-its_tab/chlamydia_pts-eng.php
  Google Scholar
• 310  Australian Government. Department of Health and Ageing. National Notifiable Diseases Surveillance System. www.health.gov.au/cda/source/CDA-index.cfm
  Google Scholar
• 311  Health Protection Agency. Sexually Transmitted Infections Annual Data. www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/STIs/STIsAnnualDataTables/#2._STI_data_tables
  Google Scholar